Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages
The District of Columbia Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legal document that outlines the terms and conditions regarding the use and ownership of intellectual property developed through the collaboration between the two entities. This agreement is specific to the District of Columbia region and aims to protect the interests of both parties involved. Keywords: District of Columbia, collateral license agreement, Gentling, Inc., University of North Texas Health Science Center, intellectual property, collaboration, terms and conditions, ownership, interests. There may be different types of District of Columbia Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center, depending on the nature and scope of the collaboration. Some possible variations could include: 1. Research & Development Agreement: This type of agreement may focus on the joint efforts of Gentling, Inc. and The University of North Texas Health Science Center in conducting research and development activities, with provisions on intellectual property ownership and shared rights. 2. Licensing and Royalty Agreement: In instances where Gentling, Inc. wishes to license certain intellectual properties developed by The University of North Texas Health Science Center, a specific agreement may be formed to outline the terms of the license, including royalties, exclusivity, and related provisions. 3. Commercialization Agreement: This agreement could be relevant when the collaboration between Gentling, Inc. and The University of North Texas Health Science Center leads to the successful development of a product or technology that requires commercialization. Terms related to marketing, manufacturing, distribution, and revenue sharing may be addressed in this type of collateral license agreement. Overall, the exact nature and purpose of the Collateral License Agreement can vary based on the specific objectives and requirements of the partnership between Gentling, Inc. and The University of North Texas Health Science Center in the District of Columbia.
The District of Columbia Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legal document that outlines the terms and conditions regarding the use and ownership of intellectual property developed through the collaboration between the two entities. This agreement is specific to the District of Columbia region and aims to protect the interests of both parties involved. Keywords: District of Columbia, collateral license agreement, Gentling, Inc., University of North Texas Health Science Center, intellectual property, collaboration, terms and conditions, ownership, interests. There may be different types of District of Columbia Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center, depending on the nature and scope of the collaboration. Some possible variations could include: 1. Research & Development Agreement: This type of agreement may focus on the joint efforts of Gentling, Inc. and The University of North Texas Health Science Center in conducting research and development activities, with provisions on intellectual property ownership and shared rights. 2. Licensing and Royalty Agreement: In instances where Gentling, Inc. wishes to license certain intellectual properties developed by The University of North Texas Health Science Center, a specific agreement may be formed to outline the terms of the license, including royalties, exclusivity, and related provisions. 3. Commercialization Agreement: This agreement could be relevant when the collaboration between Gentling, Inc. and The University of North Texas Health Science Center leads to the successful development of a product or technology that requires commercialization. Terms related to marketing, manufacturing, distribution, and revenue sharing may be addressed in this type of collateral license agreement. Overall, the exact nature and purpose of the Collateral License Agreement can vary based on the specific objectives and requirements of the partnership between Gentling, Inc. and The University of North Texas Health Science Center in the District of Columbia.